S. James Freedman
Profile
S.
James Freedman served as Co-President & Chief Executive Officer at Locus Pharmaceuticals, Inc. in 2009-2010.
He was also a Director at Quikbyte Software, Inc. and Sorrento Therapeutics, Inc. in 2009.
Additionally, he held the position of Executive Vice President-Research & Development at OPKO Health, Inc. Dr. Freedman received his undergraduate degree from McGill University and his doctorate from Tufts University.
Former positions of S. James Freedman
Companies | Position | End |
---|---|---|
Sorrento Therapeutics, Inc. /Old/
Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Director/Board Member | 2009-12-14 |
SORRENTO THERAPEUTICS, INC. | Director/Board Member | 2009-12-14 |
OPKO HEALTH, INC. | Chief Tech/Sci/R&D Officer | - |
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Director/Board Member | - |
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | President | - |
Training of S. James Freedman
McGill University | Undergraduate Degree |
Tufts University | Doctorate Degree |
Experiences
Positions held
Linked companies
Listed companies | 2 |
---|---|
OPKO HEALTH, INC. | Health Services |
SORRENTO THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Quikbyte Software, Inc.
Quikbyte Software, Inc. Financial ConglomeratesFinance The Company is develops and markets Computere Software.The Company was Founded in 1989 and it's Headquartered is in Miami,FL. | Finance |
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
Sorrento Therapeutics, Inc. /Old/
Sorrento Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Sorrento Therapeutics, Inc. develops human monoclonal antibodies based on its proprietary technology for research, diagnostic and therapeutic use. The company is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- S. James Freedman